(Formerly Microarray Data Analysis)

Genomic research has become a discipline to be integrated with clinical medicine. Currently, genomic technologies allow for the simultaneous quantification of gene activity in tissues and cells from patients. Will these genomic technologies make it possible to develop personalized medicine, leading to a more accurate diagnosis and prognosis for every patient, and subsequently, a tailored treatment strategy? With the addition and linkage of clinical parameters disparate data points are created. All agree data integration is crucial.  Join innovators from technological platform development, biostatistical analysis, biological, pharmaceutical, and clinical research as they share their experiences and insights for Integrative Data Analysis: Is Personalized Medicine at Hand?

EVENT HIGHLIGHTS

Keynote Speaker
John Quackenbush, Ph.D., Professor, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute

Conference Short Courses
Getting the Most out of Your qPCR Experiments

How to do Successful Gene Expression Analysis Using Real-time PCR

WikiLIMS™: The Next - Generation in Next-Gen Data Management

Experiment Design & Statistical Analysis of Multi-Assay Genomic Study

Break-out Discussion Groups
Exchange ideas, information, experiences and develop future collaborations

TECH EXPO
Explore available next-generation screening platforms presented by sequencing leaders

*For new registrations only. This offer does not apply to previously registered attendees and cannot be combined with any other offer.  Separate registration required for pre-conference short courses.